Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Xcel Energy Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Xcel Energy Inc trades at $75.4 (market cap $47.07B). The key difference: Xcel Energy Inc is far larger — about 5.3× Kymera Therapeutics Inc. Common Stock's market cap, and Xcel Energy Inc pays a 3.14% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Xcel Energy Inc for 61 Days on average.
| KYMR | XEL | |
|---|---|---|
Market Cap | $8.88B | $47.07B |
Volume | 1,028,790 | 4,542,292 |
Sector | Health | Utilities |
52-Week High | $127.31 | $83.91 |
52-Week Low | $55.80 | $69.39 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $8.27B | $85.39B |
Dividend Yield | — | 3.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Xcel Energy (XEL) trades at $74.64, up 0.63% with a bullish technical signal. The stock shows strong fundamentals with 2025 revenue of $14.67B and net income of $2.02B (13.75% margin). Recent earnings beat expectations in Q1 and Q2 2026, while analysts maintain a consensus buy rating with a $90.50 price target. The company benefits from rising power demand and a $60B capital expenditure plan focused on infrastructure and data center growth.
XEL offers solid growth potential driven by utility infrastructure investment and data center demand, with 62.96% analyst buy ratings supporting upside to $90.50. Key risks include wildfire liabilities, regulatory challenges, and high capital spending requirements. The stock presents a balanced opportunity for dividend-focused investors seeking regulated utility exposure with growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
